Please provide your email address to receive an email when new articles are posted on . ADR in standard colonoscopy dropped significantly from 28.4% before AI exposure to 22.4% after. Results suggest ...

The benefits of artificial intelligence (AI) in the medical space are ever-growing, but evidence suggests it can also come with risks. A new study by European researchers investigated how AI can ...

Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and specialty pharma, today announced that ColonPRO EU, the Company’s next-generation artificial intelligence software ...

Colonoscopy performed with an artificial intelligence (AI)–based computer-aided detection (CADe) system decreased the adenoma miss rate (AMR) by roughly half in comparison to standard colonoscopy ...

"Our results are concerning given the adoption of AI in medicine is rapidly spreading." HealthDay News — Exposure to artificial intelligence (AI)-assisted colonoscopy is associated with a reduction in ...

In a new study, artificial intelligence matched and potentially exceeded the performance of gastroenterologists and conventional scoring in evaluating endoscopies of Crohn's disease patients.

Artificial intelligence (AI) refers to a computer system capable of simulating human learning, understanding, problem-solving ...

The latest announcement is out from COSMO Pharmaceuticals N.V. ( ($CH:COPN) ). Cosmo Pharmaceuticals N.V. has received CE certification for its ...

Colorectal cancer is increasingly affecting younger adults, with a notable rise in cases among those under 50.

In patients with type 2 diabetes, GLP-1 receptor agonists were associated with a higher risk for gastroesophageal reflux disease (GERD) compared with SGLT-2 inhibitors. (Annals of Internal Medicine) A ...